Literature DB >> 21130495

Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.

Dan-Xia Zhu1, Kou-Rong Miao, Cheng Fang, Lei Fan, Wei Zhu, Hua-Yuan Zhu, Yun Zhuang, Ming Hong, Peng Liu, Wei Xu, Jian-Yong Li.   

Abstract

MicroRNAs (miRNAs) are a class of small endogenous RNAs that play important regulatory roles by targeting mRNAs for cleavage or translational repression. Many reports have indicated that miRNAs play a critical role in malignancies, and regulations in the progression of leukemia. However, the miRNAs expression level in Chinese patients with chronic lymphocytic leukemia (CLL), and its prognostic value remain elusive. We identified various degrees of down-regulation of miR-15a, miR-16-1, miR-29b, miR-181a and miR-181b in CLL mononuclear cells. Moreover, we have identified miR-29b and miR-181a/b expression significantly correlated with IGHV mutational status. Transcript levels of predicted target genes BCL-2 and TCL-1 were also determined, and the expression levels were significantly upregulated in CLL patients compared with normal controls (P<0.001). Higher expression of TCL-1 was significantly correlated with aggressive disease features. In addition, an inverse correlation was observed in the CLL samples we examined between miRNAs (miR-16-1, miR-181a, miR-181b) and BCL-2 level; furthermore, an inverse correlation was also observed between miRNAs (miR-16-1, miR-181a, miR-181b) and TCL-1, which suggest that these miRNAs may implicate in negatively regulating target mRNA at transcriptional level. These different miRNAs may play an important role in the pathogenesis of CLL and might be applied for the assessment of prognosis in patients with CLL.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130495     DOI: 10.1016/j.leukres.2010.11.005

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

1.  Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.

Authors:  Yuan-Dong Zhu; Li Wang; Chao Sun; Lei Fan; Dan-Xia Zhu; Cheng Fang; Yin-Hua Wang; Zhi-Jian Zou; Su-Jiang Zhang; Jian-Yong Li; Wei Xu
Journal:  Med Oncol       Date:  2011-12-31       Impact factor: 3.064

2.  Gga-miR-181a modulates ANP32A expression and inhibits MDCC-MSB-1 cell.

Authors:  X Li; C Zhao; B Han; L Qu; C Liu; N Yang; L Lian
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-03-08       Impact factor: 2.416

3.  Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.

Authors:  Shuming He; Shumei Zeng; Zhi-Wei Zhou; Zhi-Xu He; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-02-18       Impact factor: 4.162

4.  Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expression.

Authors:  Yu-Zhou He; Ru-Feng Lu; Chen Zhu; Jun-Yi Hua
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  MicroRNAs as therapeutic targets in chemoresistance.

Authors:  Michela Garofalo; Carlo M Croce
Journal:  Drug Resist Updat       Date:  2013-06-10       Impact factor: 18.500

Review 6.  MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

Authors:  Katrien Van Roosbroeck; George A Calin
Journal:  Semin Oncol       Date:  2016-02-08       Impact factor: 4.929

7.  miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review).

Authors:  Juan Liu; Weifeng Shi; Changping Wu; Jingfang Ju; Jingting Jiang
Journal:  Biomed Rep       Date:  2013-11-07

8.  MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.

Authors:  Dengbo Ji; Zhiguo Chen; Ming Li; Tiancheng Zhan; Yunfeng Yao; Zhiqian Zhang; Jianzhong Xi; Li Yan; Jin Gu
Journal:  Mol Cancer       Date:  2014-04-23       Impact factor: 27.401

9.  The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.

Authors:  Peng Han; Jing-Wen Li; Bo-Miao Zhang; Jia-Chen Lv; Yong-Min Li; Xin-Yue Gu; Zhi-Wei Yu; Yun-He Jia; Xue-Feng Bai; Li Li; Yan-Long Liu; Bin-Bin Cui
Journal:  Mol Cancer       Date:  2017-01-13       Impact factor: 27.401

10.  Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia.

Authors:  Felipe Magalhães Furtado; Priscila Santos Scheucher; Bárbara Amélia Santana; Dalila Lucíola Zanette; Rodrigo do Tocantins Calado; Eduardo Magalhães Rego; Daniel Mazza Matos; Roberto Passetto Falcão
Journal:  Rev Bras Hematol Hemoter       Date:  2017-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.